International Stem Cell Corporation (ISCO)

OTCMKTS: ISCO · Delayed Price · USD
0.450
-0.036 (-7.33%)
Jan 28, 2022 1:26 PM - Market closed
Market Cap3.60M
Revenue (ttm)3.50M
Net Income (ttm)-3.27M
Shares Out8.00M
EPS (ttm)-0.17
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,500
Open0.441
Previous Close0.486
Day's Range0.441 - 0.450
52-Week Range0.300 - 1.080
Beta0.76
Analystsn/a
Price Targetn/a
Earnings Daten/a

About ISCO

International Stem Cell Corporation focuses on the development of therapeutic and biomedical products worldwide. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, including neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; liver cells to treat various congenital and acquired liver diseases; and islet cells for the treatment of diabetes. The company also develops, manufactures, and markets skincare...

IndustryBiotechnology
Founded2001
Employees33
Stock ExchangeOTCMKTS
Ticker SymbolISCO
Full Company Profile

News

There is no news available yet.